Minority MOMP: a toxic, slow demise
Minority MOMP: a toxic, slow demise |
https://doi.org/10.18632/oncotarget.27753
Yuan Xu,
Deborah R. Surman,
and R. Taylor Ripley
|
3559-3561 |
Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential
Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential |
https://doi.org/10.18632/oncotarget.27749
Chao-Chieh Lin,
and Jen-Tsan Chi
|
3562-3570 |
Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy
Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy |
https://doi.org/10.18632/oncotarget.27731
Wojciech Dawicki,
Kevin J.H. Allen,
Ravendra Garg,
Eileen M. Geoghegan,
Mark S. Berger,
Dale L. Ludwig,
and Ekaterina Dadachova
|
3571-3581 |
PD-1/PD-L1 expression in anal squamous intraepithelial lesions
PD-1/PD-L1 expression in anal squamous intraepithelial lesions |
https://doi.org/10.18632/oncotarget.27756
Margot Bucau,
Nathalie Gault,
Nanthara Sritharan,
Emy Valette,
Charlotte Charpentier,
Francine Walker,
Anne Couvelard,
and Laurent Abramowitz
|
3582-3589 |
NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer
NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer |
https://doi.org/10.18632/oncotarget.27718
Takuma Yotsumoto,
Keita Maemura,
Kousuke Watanabe,
Yosuke Amano,
Yoko Matsumoto,
Koichi Zokumasu,
Takahiro Ando,
Masanori Kawakami,
Hidenori Kage,
Jun Nakajima,
Yutaka Yatomi,
Takahide Nagase,
and Daiya Takai
|
3590-3600 |
Meta-analysis of gene expression profiling reveals novel basal gene signatures in MCF-10A cells transformed with cadmium
Meta-analysis of gene expression profiling reveals novel basal gene signatures in MCF-10A cells transformed with cadmium |
https://doi.org/10.18632/oncotarget.27734
Katrina Blommel,
Carley S. Knudsen,
Kyle Wegner,
Swojani Shrestha,
Sandeep K. Singhal,
Aaron A. Mehus,
Scott H. Garrett,
Sonalika Singhal,
Xudong Zhou,
Brent Voels,
Donald A. Sens,
and Seema Somji
|
3601-3617 |
Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity
Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity |
https://doi.org/10.18632/oncotarget.27349
Adrienne L. Watson,
Bryant J. Keller,
Kyle A. Williams,
Namrata N. Damle,
Samuel J. Finnerty,
Leah K. Anderson,
Andrew D. Greeley,
Vincent W. Keng,
Eric P. Rahrmann,
Amanda L. Halfond,
Natasha M. Powell,
Margaret H. Collins,
Tilat Rizvi,
Christopher L. Moertel,
Nancy Ratner,
and David A. Largaespada
|
3618-3620 |